Immunova to Acquire AlphaTON Subsidiary Iox Therapeutics
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
Compare zero based budgeting with traditional budgeting to understand differences, benefits, and trade-offs. This intro helps you decide which method suits your money goals.
21,794 articlesImmunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...
SEC Chair Atkins rejects calls for immediate market intervention, outlining a rulemaking roadmap for crypto assets an...
Bitcoin liquidity tightens as the crypto native version money pool shrinks, signaling thinner market depth and sharpe...
Strategy reports a modest bitcoin purchase from its treasury amid a mid-cap crypto pullback, lifting unrealized losse...
Private exits are lagging as liquidity tightens in private markets. This report explains why the exploding secondarie...
Investors are watching Micron Technology closely as AI-driven demand reshapes memory markets. This guide explains whe...
C3.ai reports after the bell, with traders watching for signals on revenue, margins and AI platform uptake. This live...
Synopsys topped earnings and revenue expectations as AI-fueled chip design demand remains strong. Yet softer Q2 guida...
A heartfelt tribute to a TV icon offers more than nostalgia. It can spark practical money moves—funeral budgeting, es...
A lone developer demonstrates embedding an image in a single Bitcoin transaction, igniting a debate over BIP-110 data...
A prominent investment firm stepped into Black Hills Corporation, driving a 22% gain over the year. This article brea...
Leveraged ETFs promise outsized gains, but they are built for daily moves, not long-term investing. This guide breaks...